Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Viale

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|June 21, 2016
Impact of autoimmune diseases on outcome of patients with early breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Angela Esposito, et al.
Cancer Treatment Reviews|January 21, 2020
Breast implant-associated anaplastic large cell lymphoma: A comprehensive reviewAntonio Marra, Giulia Viale, Stefano A Pileri, et al.
Cancer Treatment Reviews|December 16, 2014
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatmentCarmen Criscitiello, Giulia Viale, Lucia Gelao, et al.
Expert Opinion on Pharmacotherapy|January 23, 2018
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancerBruno Achutti Duso, Dario Trapani, Giulia Viale, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 7, 2021
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in OncologyCarmen Criscitiello, Elena Guerini-Rocco, Giulia Viale, et al.
Breast (Edinburgh, Scotland)|April 1, 2023
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancerLuca Licata, Marco Mariani, Federico Rossari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2025
Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast CancerLuca Licata, Marco Mariani, Giulia Viale, et al.
British Journal of Cancer|November 7, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapyLuca Licata, Marco Barreca, Barbara Galbardi, et al.
Cancers of the Head & Neck|May 17, 2019
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literatureDaris Ferrari, Carla Codecà, Giulia Viale, et al.
JAMA Network Open|July 19, 2024
Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023Marco Mariani, Giulia Viale, Barbara Galbardi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|June 21, 2016
Impact of autoimmune diseases on outcome of patients with early breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Angela Esposito, et al.
Cancer Treatment Reviews|January 21, 2020
Breast implant-associated anaplastic large cell lymphoma: A comprehensive reviewAntonio Marra, Giulia Viale, Stefano A Pileri, et al.
Cancer Treatment Reviews|December 16, 2014
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatmentCarmen Criscitiello, Giulia Viale, Lucia Gelao, et al.
Expert Opinion on Pharmacotherapy|January 23, 2018
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancerBruno Achutti Duso, Dario Trapani, Giulia Viale, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 7, 2021
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in OncologyCarmen Criscitiello, Elena Guerini-Rocco, Giulia Viale, et al.
Breast (Edinburgh, Scotland)|April 1, 2023
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancerLuca Licata, Marco Mariani, Federico Rossari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2025
Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast CancerLuca Licata, Marco Mariani, Giulia Viale, et al.
British Journal of Cancer|November 7, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapyLuca Licata, Marco Barreca, Barbara Galbardi, et al.
Cancers of the Head & Neck|May 17, 2019
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literatureDaris Ferrari, Carla Codecà, Giulia Viale, et al.
JAMA Network Open|July 19, 2024
Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023Marco Mariani, Giulia Viale, Barbara Galbardi, et al.
Pageof 5